SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-764305
Filing Date
2016-11-09
Accepted
2016-11-09 16:02:08
Documents
53
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d247257d10q.htm 10-Q 679563
2 EX-31.1 d247257dex311.htm EX-31.1 5913
3 EX-31.2 d247257dex312.htm EX-31.2 5941
4 EX-32.1 d247257dex321.htm EX-32.1 4264
11 GRAPHIC g247257snap2.jpg GRAPHIC 36333
  Complete submission text file 0001193125-16-764305.txt   3656368

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ziop-20160930.xml EX-101.INS 436609
6 XBRL TAXONOMY EXTENSION SCHEMA ziop-20160930.xsd EX-101.SCH 40764
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ziop-20160930_cal.xml EX-101.CAL 42076
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ziop-20160930_def.xml EX-101.DEF 273802
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20160930_lab.xml EX-101.LAB 360309
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20160930_pre.xml EX-101.PRE 320203
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 646-214-0700
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 161984171
SIC: 2834 Pharmaceutical Preparations